The Role of Biologics and Biosimilars in the Management of Rheumatoid Arthritis: Considerations for the Specialty Pharmacist
This program will highlight biosimilar, their impact on RA management, and how to utilize therapies to enhance quality of life and care of patients with RA.
An American Journal of Managed Care® Supplement: Improving Provider and Patient Acceptance of Biosimilars in Treating Cancer – Clinical, Manufacturing, and Cost Considerations
This CME activity will provide pharmacists and pharmacy technicians with an overview of biosimilars from the manufacturing and regulatory perspectives.
Biological Medications and Biosimilars: The Basics
After this activity, participants should be able to review the biological and biosimilar approval pathway and what it means for clinical practice and therapeutic substitution.